Racial/ethnic differences in biologic treatment patterns among patients with psoriasis: A prospective analysis of patients in the CorEvitas Psoriasis Registry.

Autor: Enos CW; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia., Yi JZ; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia., Ormaza Vera A; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia., McLean RR; CorEvitas, LLC, Waltham, Massachusetts., Sima AP; CorEvitas, LLC, Waltham, Massachusetts., Eckmann T; CorEvitas, LLC, Waltham, Massachusetts., Van Voorhees AS; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia. Electronic address: vanvooas@evms.edu.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Oct; Vol. 91 (4), pp. 717-719. Date of Electronic Publication: 2024 May 18.

The Role of Inhalant Allergens on the Clinical Manifestations of Atopic Dermatitis.

Autor: Jung J; Divisions of Rhinology, Endoscopic Sinus Surgery, and Allergy, Department of Otolaryngology - Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA., Enos CW; Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA., Lam KK; Divisions of Rhinology, Endoscopic Sinus Surgery, and Allergy, Department of Otolaryngology - Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA., Han JK; Divisions of Rhinology, Endoscopic Sinus Surgery, and Allergy, Department of Otolaryngology - Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.

Publikováno v: American journal of rhinology & allergy [Am J Rhinol Allergy] 2024 Jul; Vol. 38 (4), pp. 258-263. Date of Electronic Publication: 2024 Apr 16.

CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells.

Autor: Cardenas KCA; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA., Enos CW; Eastern Virginia Medical School, Norfolk, Virginia, USA., Spear MR; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA., Austin DE; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA., Almofeez R; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA., Kortchak S; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA., Pincus L; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA., Guo HB; University of Georgia Cancer Center, Department of Biochemistry and Molecular Biology and the Complex Carbohydrate Research Center (CCRC), USA., Dolezal S; University of Georgia Cancer Center, Department of Biochemistry and Molecular Biology and the Complex Carbohydrate Research Center (CCRC), USA., Pierce JM; University of Georgia Cancer Center, Department of Biochemistry and Molecular Biology and the Complex Carbohydrate Research Center (CCRC), USA., Furth E; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA., Gineste C; Vaxxinity Inc, Merritt Island, Fl, USA., Kwon Y; Institute: Food and Drug Administration, CDER, MD, USA., Gelber C; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA.

Publikováno v: Current cancer drug targets [Curr Cancer Drug Targets] 2024; Vol. 24 (7), pp. 720-732.

Proportions of Biologic Discontinuation Among Psoriasis Patients With Metabolic Comorbidities.

Autor: Enos CW; Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA., Ramos VL; Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA., McLean RR; CorEvitas LLC, Waltham, MA, USA., Lin TC; CorEvitas LLC, Waltham, MA, USA., Foster N; CorEvitas LLC, Waltham, MA, USA., Dube B; CorEvitas LLC, Waltham, MA, USA., Van Voorhees AS; Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA.

Publikováno v: Journal of psoriasis and psoriatic arthritis [J Psoriasis Psoriatic Arthritis] 2023 Jan; Vol. 8 (1), pp. 7-10. Date of Electronic Publication: 2022 Sep 30.

Cardiometabolic multimorbidity is common among patients with psoriasis and is associated with poorer outcomes compared to those without comorbidity.

Autor: Enos CW; Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA., Ramos VL; Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA., McLean RR; CorEvitas, LLC, Waltham, MA, USA., Lin TC; CorEvitas, LLC, Waltham, MA, USA., Foster N; CorEvitas, LLC, Waltham, MA, USA., Dube B; CorEvitas, LLC, Waltham, MA, USA., Van Voorhees AS; Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA.

Publikováno v: The Journal of dermatological treatment [J Dermatolog Treat] 2022 Nov; Vol. 33 (7), pp. 2975-2982. Date of Electronic Publication: 2022 Jul 06.